Benign prostatic hyperplasia affects approximately 50% of men by age 60 and over 90% by age 85. The urinary symptoms it causes — urgency, frequency, nocturia, weak stream — significantly impact quality of life. Despite being highly treatable, many men don't seek care because they assume these changes are an inevitable part of aging.

Tadalafil's Dual FDA Approval

Tadalafil (Cialis) holds two distinct FDA approvals:

Many men over 50 who have BPH also have ED — the two conditions frequently coexist because they share underlying mechanisms (smooth muscle dysfunction driven by the nitric oxide/cGMP pathway). Tadalafil's dual approval eliminates the need for two separate medications.

How Tadalafil Works for BPH

The standard first-line BPH treatment is alpha-blockers (tamsulosin/Flomax) — they relax smooth muscle in the prostate and bladder neck. Tadalafil works through a different pathway: PDE5 inhibition allows cGMP to build up, relaxing smooth muscle in the prostate, bladder neck, and urethra via the nitric oxide pathway — reducing the obstruction that causes urinary symptoms. Simultaneously, PDE5 inhibition in penile vasculature increases blood flow, addressing ED.

Clinical Evidence

Tadalafil vs Tamsulosin: How to Choose

Absolute contraindication
Tadalafil + nitrate medications (nitroglycerin, isosorbide, amyl nitrate/poppers) causes life-threatening hypotension with no exceptions. Disclose all cardiovascular medications before prescribing.

What to Expect on Daily Tadalafil

Related: Tadalafil vs Sildenafil: What's the Difference? · Tadalafil 5mg Daily: What to Expect Week by Week